ABC-201 Site 705

Nahariya

0 studies enrolling now · 1 studies all time

What they study most

COVID-19, Lung Infection

Studies at this site

• Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia — Completed